These findings are reminiscent of breast or endometrial cancer, in which PIK3CA mutations are frequently detected in settings of low PTEN expression or mutations [53], [54], and suggest that genetic alterations of the PI3K/AKT pathway in NSCLCs are not functionally redundant. This evidence concerns the gene PIK3CG and endometrial cancer.